Abstract:Background: Type 2 diabetes mellitus (T2DM) is a commonly observed metabolic anomaly globally, and as of the present time, there's no recognized solution. There is an increasing body of evidence from numerous observational studies indicating a significant correlation between gut flora and metabolic disease progression, particularly in relation to T2DM. Despite this, the direct impact of gut microbiota on T2DM isn't fully understood yet. Methods: The summary statistical figures for intestinal microbiota were sourced from the MiBioGen consortium, while the summary statistical data for T2DM were gathered from the Genome-Wide Association Studies (GWAS) database. These datasets were used to execute a two-sample Mendelian randomization (MR) investigation. The Inverse Variance Weighted (IVW), Maximum Likelihood, MR-Egger, Weighted Median, and Weighted Models strategies were employed to assess the impact of gut microbiota on T2DM. Findings were primarily obtained using the IVW technique. Techniques like MR-Egger were employed to identify the occurrence of horizontal pleiotropy among instrumental variables. Meanwhile, Cochran's Q statistical measures were utilized to assess the variability or heterogeneity within these instrumental variables. Results: The outcomes from the IVW analysis demonstrated that the genus Alistipes (OR = 0.998, 95% confidence interval: 0.996–1.000, and P = 0.038), genus Allisonella (OR = 0.998, 95% confidence interval: 0.997-0.999, P = 0.033), genus Flavonifractor (OR = 0.995, 95% confidence interval: 0.993–0.998, P = 3.78 × 10 −3 ), and genus Haemophilus (OR = 0.995, 95% confidence interval: 0.993–0.998, P = 8.08 × 10 −3 ) all acted as defense elements against type 2 diabetes. Family Clostridiaceae1 (OR = 1.003, 95% confidence interval: 1.001–1.005, P = 0.012), family Coriobacteriaceae (OR = 1.0025, 95% confidence interval: 1.000–1.005, P = 0.043), genus Actinomyces (OR = 1.003,95% confidence interval: 1.001–1.005, P = 4.38 × 10 −3 ), genus Candidatus Soleaferrea (OR = 1.001,95% confidence interval: 1.000–1.002 P = 0.012) were risk factors for type 2 diabetes. False Discovery Rate correction was performed with finding that genus. Allisonella , genus .Alistipes , family Coriobacteriaceae and T2DM no longer displayed a significant causal association. In addition, no significant heterogeneity or horizontal pleiotropy was found for instrumental variable. Conclusion: This MR study relies on genetic variation tools to confirm the causal effect of genus Flavonifractor , genus Haemophilus , family Clostridiaceae1 , genus Actinomyces and genus Candidatus Soleaferrea on T2DM in the gut microbiome, providing new directions and strategies for the treatment and early screening of T2DM, which carries significant clinical relevance. To develop new biomarkers and better understand targeted prevention strategies for T2DM, further comprehensive investigations are required into the protective and detrimental mechanisms exerted by these five genera against T2DM.

The relationship between gut microbiota and susceptibility to type 2 diabetes mellitus in rats

Relationship between gut microbiota and diabetes mellitus

Investigation of Gut Microbiome Changes in Type 1 Diabetic Mellitus Rats Based on High-Throughput Sequencing.

Abnormal Gut Microbiota Composition Contributes to the Development of Type 2 Diabetes Mellitus in Db/db Mice

Gut microbiota mediate melatonin signalling in association with type 2 diabetes

Relationship between gut microbiota, obesity and diabetes

Gut Microbiota and Type 2 Diabetes Mellitus: Association, Mechanism, and Translational Applications

The causal relationship between gut microbiota and type 2 diabetes: a two-sample Mendelian randomized study

A study on the association between gut microbiota, inflammation, and type 2 diabetes

Causal relationships between gut microbiota, gut metabolites, and diabetic neuropathy: A mendelian randomization study

Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus

Role of gut microbiota in type 2 diabetes pathophysiology

Gut Bacterial Characteristics of Patients With Type 2 Diabetes Mellitus and the Application Potential

The mechanisms in the gut microbiota regulation and type 2 diabetes therapeutic activity of resistant starches

The Effects of Diet and Streptozotocin on Metabolism and Gut Microbiota in a Type 2 Diabetes Mellitus Mouse Model

Implication of the gut microbiome composition of type 2 diabetic patients from northern China

Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications

Causal relationship between gut microbiota and type 2 diabetes: a two-sample Mendelian randomization study

A metagenome-wide association study of gut microbiota in type 2 diabetes

Research progress on relationship between type 2 diabetes, gut microbiota and probiotics